KP-N-RT-BM-1Homo sapiens (Human)Cancer cell line
Also known as: Kyoto Pediatrics-Neuroblastoma-RT-Bone Marrow, KP-N-RT, RT-BM, KP-N-RTBM, KP-N-RT-BM, RTBM1, RT-BM 1, RT-BM-1, KPNRTBM1
KP-N-RT-BM
Quick Overview
Human neuroblastoma cell line with potential for cancer research.
Detailed Summary
Basic Information
Database ID | CVCL_1339 |
---|---|
Species | Homo sapiens (Human) |
Tissue Source | Bone marrow[UBERON:UBERON_0002371] |
Donor Information
Age | 1 |
---|---|
Age Category | Pediatric |
Sex | Female |
Subtype Features | MYC_Amplified |
Disease Information
Disease | Neuroblastoma |
---|---|
Lineage | Peripheral Nervous System |
Subtype | Neuroblastoma |
OncoTree Code | NBL |
DepMap Information
Source Type | HSRRB |
---|---|
Source ID | ACH-000345_source |
Haplotype Information (STR Profile)
Short Tandem Repeat (STR) profile for cell line authentication.
Loading gene expression data...
Publications
Pan-cancer proteomic map of 949 human cell lines.";
Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.
Cancer Cell 40:835-849.e8(2022).
Next-generation characterization of the Cancer Cell Line Encyclopedia.
Sellers W.R.
Nature 569:503-508(2019).
An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.
Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.
Cancer Res. 79:1263-1273(2019).
A landscape of pharmacogenomic interactions in cancer.";
Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
Cell 166:740-754(2016).
TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.
Loewer M., Sahin U., Castle J.C.
Genome Med. 7:118.1-118.7(2015).
A resource for cell line authentication, annotation and quality control.
Neve R.M.
Nature 520:307-311(2015).
A MYCN-amplified cell line derived from a long-term event-free survivor among our sixteen established neuroblastoma cell lines.
Ohta S., Ohira M., Nakagawara A.
Cancer Lett. 331:115-121(2013).
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.
Nature 483:603-607(2012).
Signatures of mutation and selection in the cancer genome.";
Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.
Nature 463:893-898(2010).
High-resolution detection and mapping of genomic DNA alterations in neuroblastoma.
Maris J.M.
Genes Chromosomes Cancer 43:390-403(2005).
PPM1D is a potential target for 17q gain in neuroblastoma.";
Sugimoto T., Inazawa J.
Cancer Res. 63:1876-1883(2003).
Detection of the retinoic acid-regulated genes in a RTBM1 neuroblastoma cell line using cDNA microarray.
Ueda K.
Kurume Med. J. 48:159-164(2001).
Neuroblastoma cell lines showing smooth muscle cell phenotypes.";
Komada M., Asada Y., Sawada T.
Diagn. Mol. Pathol. 9:221-228(2000).
Identical expression of cell surface membrane antigens on two parent and eighteen cloned cell lines derived from two different neuroblastoma metastases of the same patient.
Horii Y., Morioka H., Morita M., Reynolds C.P.
Cancer Res. 46:4765-4769(1986).
Neuroblastoma.";
Thiele C.J.
(In book chapter) Human cell culture. Vol. 1. Cancer cell lines part 1; Masters J.R.W., Palsson B.O. (eds.); pp.21-53; Kluwer Academic Publishers; New York; USA (1999).